Efficient genome editing in zebrafish using a CRISPR-Cas system

Area of Science:

• Molecular Biology
• Genetics
• Developmental Biology

Background:

• Clustered, regularly interspaced, short palindromic repeats (CRISPR)--CRISPR-associated (Cas) systems are bacterial defense mechanisms against foreign nucleic acids.
• Bacterial type II CRISPR systems, specifically the Cas9 endonuclease, have been engineered with guide RNAs for targeted DNA cleavage in cellular systems.

Purpose of the Study:

• To investigate the efficacy of the CRISPR-Cas system for inducing targeted genetic modifications in vivo.
• To compare the efficiency of CRISPR-Cas gene editing in zebrafish embryos with existing technologies like zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs).

Main Methods:

• Adaptation of bacterial type II CRISPR-Cas system components (Cas9 endonuclease and guide RNA) for use in eukaryotic systems.
• Introduction of the CRISPR-Cas system into zebrafish embryos to achieve site-specific DNA cleavage and subsequent genetic modification.

Main Results:

• Demonstration that the CRISPR-Cas system functions effectively in vivo within zebrafish embryos.
• Achieved targeted genetic modifications with efficiencies comparable to those obtained using established gene editing tools such as ZFNs and TALENs.

Conclusions:

• The CRISPR-Cas system is a potent tool for in vivo genome engineering in zebrafish embryos.
• CRISPR-Cas technology offers a highly efficient and versatile alternative for genetic manipulation in developmental biology research.